The microRNA-cell surface proteoglycan axis in cancer progression

Am J Physiol Cell Physiol. 2022 May 1;322(5):C825-C832. doi: 10.1152/ajpcell.00041.2022. Epub 2022 Mar 16.

Abstract

Proteoglycans consist one of the major extracellular matrix class of biomolecules that demonstrate nodal roles in cancer progression. Modern diagnostic and therapeutic approaches include proteoglycan detection and pharmacological targeting in various cancer types. Proteoglycans orchestrate critical signaling pathways for cancer development and progression through dynamic interactions with matrix components. It is well established that the epigenetic signatures of cancer cells play critical role in guiding their functional properties and metastatic potential. Secreted microRNAs (miRNAs) reside in a complex network with matrix proteoglycans, thus affecting cell-cell and cell-matrix communication. This mini-review aims to highlight current knowledge on the cell-surface proteoglycan-mediated signaling cascades that regulate miRNA biogenesis in cancer. Moreover, the miRNA-mediated proteoglycan regulation during cancer progression and mechanistic aspects on the way that proteoglycans affect miRNA expression are presented. Recent advances on the role of cell surface proteoglycans in exosome biogenesis and miRNA packaging and expression are also discussed.

Keywords: cancer progression; extracellular matrix; glypicans; miRNAs; syndecans.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Extracellular Matrix / metabolism
  • Humans
  • MicroRNAs* / metabolism
  • Neoplasms* / metabolism
  • Proteoglycans / genetics
  • Proteoglycans / metabolism
  • Signal Transduction / physiology

Substances

  • MicroRNAs
  • Proteoglycans